Zusammenfassung
Die Entwicklung wirksamer und zuverlässiger Impfverfahren ist von einer Reihe von Voraussetzungen abhängig, die in Hinsicht auf die Poliomyelitis erst in jüngster Vergangenheit erfüllt werden konnten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anders, W.: 1. Lagebericht des Bundesgesundheitsamts. „Über die Kinderlähmung”. 1963.
Anders, W.: Die Poliomyelitis-Situation in der Bundesrepublik und in Europa. Ärztl. Mitt. S. 1691. (1962).
Anderson: zit. n. Wiesmann u. Wegmann (1962).
Armstrong, C.: The experimental transmission of poliomyelitis to the Eastern cotton rat, Sigmodon hispidus hispidus. Publ. Hlth Rep. 54, 1719 (1939 a).
Armstrong, C.: Successful transfer of the Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Publ. Health Eep. 54, 2302 (1939b).
Barnett, E., and S. Baron: Antibody Response to Increased Amounts of Poliomyelitis vaccine. Amer. J. Hyg. 71 59 (1960).
Batson, R., A. Christie and W. Cheatham: The infant’s serologic response to live poliomyelitis virus vaccine. J. Amer. med. Ass. 180, (1962).
Bauer, H., R. Barr, H. Kleinman, A. Kimball, M. Cooney, J. Bearman and W. Mathey: Minnesota studies with oral poliomyelitis vaccines. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 357. Washington D. C., 1960.
Baumann, Th., u. Felder: Begleiterscheinungen und Komplikationen bei der Vaccination gegen Poliomyelitis. Schweiz. med. Wschr. 87, 964 (1957).
Belian, W.: Virologische und serologische Auswertung der Schutzimpfung in der DDR im Jahre 1960 mit der Lebend-Polio-Vakzine nach Sabin-Tschumakow. Zbl. Bakt., I. Abt. Orig. 184, 150 (1962).
Bhatt, P., M. Brooks and J. Fox: Extent of infection with poliomyelitis virus in household associated of clinical cases as determinded serologically and by virus isolation using tissue culture methods. Amer. J. Hyg. 61, 287 (1955).
Bodian, D.: Experimental studies of passive immunization against poliomyelitis. II. The prophylactic effect of human gammaglobulin on paralytic poliomyelitis in cynomolgus monkeys after virus feeding. Amer. J. Hyg. 56, 78 (1952).
Bodian, D.: III. Passive-active immunization and pathogenesis after virus feeding in chimpanzees. Amer. J. Hyg. 58, 81 (1953).
Bodian, D.: Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the “provocing” effect of injections or trauma. Amer. J. Hyg. 60, 358 (1954).
Bodian, D.: Viremia, invasiveness and the influence of injections. Ann. N. Y. Acad. Sci. 61, 877 (1955).
Bodian, D. and H. Howe: Non paralytic poliomyelitis in the Chimpanzee. J. exp. Med. 81, 255 (1945).
Bodian, D. and H. Howe and R. S. Paffenberger: Poliomyelitis infections in households. Frequency of viremia and specific antibody response. Amer. J. Hyg. 60, 83 (1954).
Bodian, D. and H. Howe and R. S. Paffenberger, and N. Nathanson: Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in Chimpanzees. Bull. Johns Hopk. Hosp. 107, 143 (1960).
Brodie, M., u. W. H. Park: (Zit. n. Vivell) J. Amer. med. Ass. 105, 1089 (1935).
Brownlee, K. A.: Statistics of the 1954 Poliovaccine Trials. J. Amer. Statist. Assoc. 50, 1005 (1955).
Bundesgesundheitsamt: Zweites Gutachten über den Stand der Schutzimpfung gegen die spinale Kinderlähmung. Abh. aus d. Bundesgesundheitsamt 3. Berlin-Göttingen-Heidelberg: Springer 1959.
Burnet, F. M., and J. Macnamara: Immunological differences between strains of poliomyelitis virus. Brit. J. exp. Path. 12, 57 (1931).
Charney, J., A. A. Tytell, R. A. Machlowitz and M. R. Hilleman: Development of an Purified Poliomyelitis Virus Vaccine. J. Amer. med. Ass. 177, 591 (1961).
Christensen, Ch. N.: Reactions to poliomyelitis vaccine. J. Amer. med. Ass. 171, 869 (1959).
Chumakov, M. P.: On Mass oral Immunization of Population in the Soviet Union against Poliomyelitis with Live Vaccine from A. B. Sabin’s Attenuated Strains. Report No. 2 Academy of Medical Sciences of the USSR, Institute for Poliomyelitis Research. Moscow 1960.
Chumakov, M. P.: Some results of the work on mass immunization of the population in the Soviet Union with live poliovirus Vaccine from Albert B. Sabin’s strains. The control of poliomyelitis by live poliomyelitis vaccine. Edited by J. Weissfeiler. Budapest 1961.
Commitee on Typing of the National Foundation for Infantile Paralysis: Immunologic classification of poliomyelitis viruses: Discussion of results and general summary. Amer. J. Hyg. 54, 191 (1951).
Dane, D., G. Dick, J. Comolly, O. Fisher and F. McKeown: Vaccination against poliomyelitis with live virus vaccines. Brit. med. J. 1957 I, 59.
Dane, D., G. Dick, J. Comolly, O. Fisher and F. McKeown, M. Briggs, R. Nelson, J. McAlister, J. Conolly, M. Haire, F. McKeown and D. Field: Vaccination against poliomyelitis with the live virus vaccines. VI Changes in Sabin type II oral vaccine virus after human passage. Brit. med. J. 1961a II 259.
Dane, D., G. Dick, M. Briggs, R. Nelson, J. McAllister, J. Conolly, M. Haire, F. McKeown and C. Field: Vaccination against poliomyelitis with live virus vaccines. VIII. Changes in Sabin type I oral vaccine virus after multiplication in the intestinal tract. Brit. med. J. 1961 b/II, 269.
Dane, D. S., C. W. A. Dick, J. J. McAlister and R. T. Nelson: Epidemic control of poliomyelitis with inactive virus vaccines. Studies in cynomolgus monkeys. Lancet 1960 I, 845.
Dick, G., D. Dane, J. McAlister, M. Briggs, R. Nelson and C. Field: Vaccinations against poliomyelitis with live virus vaccines. VII. Effect of previous Salk vaccination on virus-excretion. Brit. med. J. 1961 II, 266.
Dulbecco, R., and M. Vogt: Plaque formation and isolation of pure lines with poliomyelitis viruses. J. exp. Med. 99, 167 (1954).
Ehrengut, W., u. H. Rüstow: Zusammenhänge zwischen Pockenschutzimpfung und Poliomyelitis. Öff. Gesundh.-Dienst 19, 64 (1957).
Enders, J., T. Weller and F. Robbins: Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109, 85 (1949).
Enders, J., T. Weller and F. Robbins: Alteration in pathogenicity for monkeys of Brunhilde strain of poliomyelitis following cultivation in human tissues. Fed. Proc. 11, 467 (1952).
Flexner, S., and P. A. Lewis: The nature of the virus of epidemic poliomyelitis. J. Amer. med. Ass. 53, 2095 (1909).
Flexner, S., and P. A. Lewis: Experimental poliomyelitis in monkeys. Seventh note: Active immunization and passive serum protection. J. Amer. med. Ass. 54, 1780 (1910).
Fox, J., H. Gelfand, P. Bhatt, D. Le Blanc and D. Conwell: Immunizing infections with poliomyelitis viruses and seroimmune patterns in Southern Louisiana. Ann. N. Y. Acad. Sci. 61, 968 (1955).
Fox, J., H. Gelfand, P. Bhatt, D. Le Blanc and D. Conwell D. Le Blanc, H. M. Gelfand, D. J. Clemmer and L. Potash: Spread of a vaccine strain of poliomyelitis in Southern Louisiana communities. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 144. Washington D. C., (1960).
Francis-Bericht: Evaluation of 1954 Field Trial of Poliomyelitis vaccine. Summary Report. Vaccine Evaluation Center University of Michigan. Ann Arbor, Michigan April 12, 1955.
Francis jr., T.: Evaluation of the 1954 poliomyelitis vaccine field Trial. Further studies of results determining the effectiveness of poliomyelitis vaccine (Salk), in proventing paralytic poliomyelitis. J. Amer. med. Ass. 158, 1266 (1955).
Francis jr., T. R. F. Korns, R. B. Voight, M. Boisen, F. M. Hephill, J. A. Napier and E. Tolchinsky: An evaluation of the 1954 poliomyelitis vaccine Trials. Summary report. Amer. J. publ. Hlth, Part 2, 45, 1 (1955).
Gaisford, W., G. Feldman and F. Perkins: The response of infants to poliomyelitis immunization after neonatal immunization with tripleantigen. J. Pediat. 58, 493 (1961).
Gard, S.: The virus of Poliomyelitis. In: D. Hallauer u. K. F. Meyer: Handbuch der Virusforschung, 4. Band, S. 581. Wien: Springer 1958.
Gard, S.: Field and laboratory experiences with the CHAT strain type I poliovirus. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Internat. Bureau. Washington D. C.: Scientific Publication 50, 187 (1960).
Gelfand, H. M., A. H. Holguin and R. A. Feldman: Community-wide type 3 oral poliovirus vaccinetion in Atlanta, Ga. (1961). J. Amer. med. Ass. 181, 281 (1962).
Graser, F., u. G. Fortong: Nervöse Komplikationen bei der Poliomyelitisschutzimpfung. Mschr. Kinderheilk. 107, 227 (1959).
Haas, R., u. W. Keller: Zur Problematik der Unschädlichkeitsprüfung von Poliomyelitisimpfstoffen und gegenwärtigen Stand ihrer praktischen Anwendung. Dtsch. med. Wschr. 82, 1042 (1957).
Haas, R., u. R. Thomssen: Über den Entwicklungsstand der in der Immunbiologie gebräuchlichen Adjuvantien. Ergebn. Mikrobiol. 34, 27 (1961).
Haas, R., u. R. Thomssen V. Dostal, J. Lindemann, G. Maas u. R. Thomssen: Virologische Untersuchungen nach oraler Poliomyelitis-Schutzimpfung (Sabin). I. Untersuchungen über Virusausscheidung, Antikörperbildung und die Häufigkeit von Kontaktinfektionen. Dtsch. med. Wschr. 86, 2413 (1961).
Hale, J. H., M. Doraisingham, L. H. Lee, K. Koragaratnam, K. W. Leong and E. S. Monteiro: Large-scale use of Sabin Type 2 attenuated poliovirus vaccine in Singapore during a Type 1 poliomyelitis epidemic. First Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 44, 286. Washington D. C., 1959.
Hale, J., L. Lee and P. Gardner: Interference patterns encountered when using attenuated poliovirus vaccines. Brit. med. J. 1961 II 728.
Hammon, W., L. L. Coriell, P. F. Wehrle and J. Stokes: Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis. 4. Final report of results based on clinical diagnosis. J. Amer. med. Ass. 151, 1272 (1953).
Hammon, W., L. L. Coriell, P. F. Wehrle and J. Stokes, E. H. Ludwig, R. M. McAllister, A. E. Greene, G. E. Sather and P. F. Wehrle: Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory confirmed cases. J. Amer. med. Ass. 156, 21 (1954).
Hein, E.: Erfahrungen über die Polioschluckimpfung in Bayern und weitere Ausblicke. Bayer. Ärztebl. 17, 538 (1962).
Henneberg, G.: Poliomyelitis-Schutzimpfung mit Lebendimpfstoff (Cox) in Berlin im Mai 1960. Bundesgesundheitsblatt 1962, 153.
Hilber, H.: Differentialdiagnostische Erwägungen bei Begleiterscheinungen der Polioschluckimpfung. Bayer. Ärztebl. 17, 448 (1962).
Holt, L. B.: A re-assessment of the risk of provoking paralytic poliomyelitis by making prophylactic inoculations against diphtheria and pertussis. J. Hyg. 57, 150 (1959).
Horstmann, D., and R. McCollum: Poliomyelitis virus in human blood during the “minor illness” and the asymptomatic infection. Proc. Soc. exp. Biol. (N. Y.) 82, 434 (1953).
Horstmann, D., and R. McCollum and A. Maseola: Viremia in human poliomyelitis. J. exp. Med. 99, 355 (1954).
Howe, H.: Poliomyelitis Infection in Immunized Chimpanzees. Ann. N. Y. Acad. Sci. 61, 1014 (1955).
Howe, H.: The quantitation of poliomyelitis virus in the human alimentary tract with reference to co-existency levels of homologous serum neutralizing antibody. Amer. J. Hyg. 75, 1 (1962).
Joppich, G.: Die orale Poliomyelitisimpfung in der Bundesrepublik. Ärztl. Mitt. (Köln) 3, 139 (1963).
Kanda, Y., and J. Melnick: In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J. exp. Med. 109 9 (1959).
Kleinman, H., R. N. Barr, H. Bauer, A. C. Kimball, M. K. Cooney, J. E. Bearman and W. E. Mathey: A Comparison of Monovalent and Trivalent Vaccines. Second International Conference on Live Poliomyelitis Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 341. Washington D. C, 1960.
Kleinschmidt, H.: Die Beurteilung von Impfschäden —Meldungen nach Impfung gegen Kinderlähmung. Paediat. int. (Roma) 9, 635 (1959).
Kochs, H.: Zur oralen Schutzimpfung gegen Poliomyelitis in West-Berlin 1960. Bundesgesundheitsblatt 1961 149.
Kolmer, J. A., G. F. Klugh u. J. Rule: Zit. n. Vivell. J. Amer. med. Ass. 104 456 (1935).
Koprowski, H., G. Hervis and Th. Norton: Immune responses in human volonteers upon administration of a rodent adapted strain of poliomyelitis virus. Amer. J. Hyg. 55, 108 (1952).
Koprowski, H., G. Hervis and Th. Norton: Historical aspects of the development of live virus vaccines in poliomyelitis. Amer. J. Dis. Child. 100 428 (1960).
Koprowski, H., G. Hervis and Th. Norton and D. Nelson: Further studies on oral administration of living poliomyelitis virus to human subjects. Proc. Soc. exp. Biol. (N. Y.) 82, 277 (1953).
Krugman, S., J. Warren, M. S. Eiger, P. H. Herman, R. M. Michaels and A. B. Sabin: Immunization with live attenuated polio virus vaccine. Amer. J. Dis. Child. 101 23 (1961).
Landsteiner, K.: Erster Bericht über die Übertragbarkeit der Poliomyelitis in der Sitzung der Gesellschaft der Ärzte in Wien am 18. Dezember 1908. Wien. klin. Wschr. 21, 1830 (1908).
Langmuir, A. D., N. Nathanson and W.J. Hall: Surveillance of poliomyelitis in the United States in 1955. Amer. J. publ. Hlth 46, 75 (1956).
Langmuir, A. D., N. Nathanson and W.J. Hall: „Inaktivierte Virusvakzine“; Schutzwirkung”. 5. Internat. Poliomyelitiskonferenz, Kopenhagen 1960. Excerpta Medica. Internat. Congress Series No. 27. Alete-Reihe 2, Berichterstattung von Schweier und Vivell, S. 29 (1960). Herausgeber: „Alete“ Pharmaz. Produkte G. m. b. H. München.
Langmuir, A. D.: Epidemiologic Considerations. J. Amer. med. Ass. 175, 840 (1961).
Lennartz, H., u. L. Valenciano: Virologische Untersuchungen zur oralen Schutzimpfung gegen Poliomyelitis in Westberlin 1960. Dtsch. med. Wschr. 86, 1497 (1961).
Lepow, M. L., R. J. Warren, V. G. Ingram, S. C. Dangherty and F. C. Robbins: Sabin type I (L Sc 2 a b) oral poliomyelitis vaccine. Effect of dose upon response of newborn infants. Amer. J. Dis. Child. 104, 67 (1962).
Levine, S., N. Goldblum and C. Friedman: Virologie findings and antibody response of newborn fed multiple type oral poliomyelitis vaccine. Amer. J. Hyg. 74, 59 (1961).
Li, C., and K. Habel: Adaptation of Leon strain of poliomyelitis to mice. Proc. Soc. exp. Biol. (N. Y.) 78, 233 (1951).
Li, C., and K. Habel, and M. Schaeffer: Adaptation of type I poliomyelitis virus to mice. Proc. Soc. exper. Biol. (N. Y.) 82, 477 (1953).
Li, C., and K. Habel, and M. Schaeffer: Isolation of non-neurotropic variants of type I poliomyelitis virus. Proc. Soc. exper. Biol. (N. Y.) 87, 148 (1954).
Li, C., and K. Habel, and M. Schaeffer and D. Nelson: Experimentally produced variants of poliomyelitis virus combining in vivo and in vitro techniques. Ann. N. Y. Acad. Sci. 61, 902 (1955).
Liebe, S., u. W. Wöckel: Landrysche Paralyse nach Poliomyelitisschutzimpfung. Dtsch. med. Wschr. 84, 909 (1959).
Lwoff, A.: Factors influencing the evolution on viral diseases at the cellular level and in the organism. Bact. Rev. 23, 100 (1959).
Maròczi, I.: Vaccinia-Antihämagglutinintiter des Serums der nach einer mit lebender, geschwächter Poliovirusvakzine ausgeführten Impfung mit Pockenlymphe geimpften Säuglinge. Orv. Hetil. 3, 104 (1963).
McBride, W. D.: Antigenic analysis of polioviruses by kinetic studies of serum neutralization. Virology 7, 45 (1959).
Melnick, J. L., M. Benyesh-Melnick and J. C. Brennan: Studies on live poliovirus vaccine. Its neurotropic activity in monkeys and its increased neurovirulence after multiplication in vaccinated Children. J. Amer. med. Ass. 171, 1165 (1959).
Melnick, J. L., M. Benyesh-Melnick and J. C. Brennan: Problems associated with the live poliovirus vaccine and its progeny after multiplication in man. Second Internat. Conference on Live Polio Virus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 12. Washington D. C., 1960.
tMelnick, J. L., M. Benyesh-Melnick and J. C. Brennan, R. Penna and M. Yow: Effectiveness of Salk-Vaccine. J. Amer. med. Ass. 175, 1159 (1961).
Miller, H. G., and J. B. Stanton: Neurological sequelae of prophylactic inoculation. Quart. J. Med., New Series XXIII, 89(1954).
Müller, H.: Die Kinderlähmung in Altbayern. Münch. med. Wschr. 1938, 353.
Munk, K.: Über die Immunität gegen Poliomyelitis. Untersuchungen mit dem Neutralisationstest. Münch. med. Wschr. 99, 1781 (1957).
Murray, R.: Inaktivierte Vakzine-Schutzimpfung. Standardisierung der Aktivität. 5. Internat. Poliomyelitiskonferenz, Kopenhagen 1960. Excerpta Medica. Internat. Congress Series No. 27. Alete-Reihe 2, Berichterstattung von Schweier und Vivell, S. 38 (1960) Herausg.: Alete Pharm. Produkte GmbH. München.
Nathanson, N., L. D. Thrupp, W. M. J. Hall, A. D. Langmuir, R. G. Cornell, H. E. Forester, R. E. Churon, J. B. Hall, M. Hildebrand, H. J. Shanghnessy and R. Morrissey: Epidemic poliomyelitis during 1956 in Chicago and Cook Country, Illinois. Amer. J. Hyg. 70, 107 (1959).
Niederman, J. C., D. M. Horstmann and E. M. Opton: A survey of poliomyelitis antibody levels in New Haven, Connecticut, 1957–1958. Amer. J. Hyg. 72, 218 (1960).
Paul, J. R.: Status of vaccination against poliomyelitis with particular reference to oral vaccination. New Engl. J. Med. 264, 651 (1961).
Pfaundler, M.: Über stille Feiung (erläutert am Beispiel der Heine-Medinschen Krankheit). Münch, med. Wschr. 75, 45 (1928).
Prem, K., and J. McKelvey: Immunologic response of pregnant women to oral trivalent poliomyelitis vaccine. First International Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 44, 260. Washington D. C., 1959.
Prem, K., and J. McKelvey: J. W. Fergus, J. E. Mathers and L. McKelvey: Vaccination of pregnant women and young infants with trivalent oral attenuated live poliomyelitis vaccine. Second internat. conference on live polio-virus vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 207. Washington D. C., 1960.
Prigge, R., O. Günther, O. Bonin, G. Eissner unter Mitwirkung von J. Hallervorden u. J. W. Spaar: Probleme der staatlichen Prüfung von Poliomyelitis-Impfstoffen. Dtsch. med. Wschr. 81, 325, 377 (1956).
Raettig, H.: Die Provokation einer Infektionskrankheit durch Schutzimpfung. Bundesgesundheitsbl. 9, 129 (1958).
Raettig, H.: Die epidemiologischen Auswirkungen der Poliomyelitis-Impfung in West-Berlin. Zbl. Bakt., I. Abt. Orig. 184, 142 (1962).
Ramon, G.: Vaccination contre la poliomyélite et vaccination antidiphthérique. Resultats respectifs. Etude comporative. Conclusion. Rev. Immunol. (Paris) 27, 469 (1960).
Ramos Alvarez, M., M. Bustamente and R. Alvarez Alba: Use of Sabin’s live poliovirus vaccine in Mexico. Results of a large-scale trial. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 386. Washington D. C., 1960.
Ratner, H., H. R. Cox, B. G. Greenberg, H. Kleinman and P. Meier: (Panel-Discussion) The Present Status of Polio Vaccines. Illinois med. J. 2, 118 (1960).
Revenok, N. D.: Observations over children inoculated with live poliovirus vaccine during the incubation period of measles. Zit. n. Zbl. Kinderheilk. 83, 272 Pediatriya (Moskau) 40 54 (1961).
Rivers, T. M.: Zit. n. Vivell (1958). J. publ. Hlth 26, 136 (1936).
Roca-Garcia, M., A. Moyer and H. Cox: Poliomyelitis. I. Propagation of the MEF 1 strain of poliomyelitis virus in the sockling hamster. Proc. Soc. exp. Med. (N. Y.) 81, 513 (1952a).
Roca-Garcia, M., A. Moyer and H. Cox: Poliomyelitis. II. Propagation of MEF 1 strain of poliomyelitis virus in developing chick embryo by Yolk sac inoculation. Proc. Soc. exp. Med. (N. Y.) 81, 519 (1952b).
Römer, P. H.: Weitere Mitteilungen über experimentelle Affenpoliomyelitis. Münch. med. Wschr. 57, 229 (1910).
Sabin, A.: Characteristics and genetic potentialities of experimentally produced and naturally occuring variants of poliomyelitis virus. Ann. N. Y. Acad. Sci. 61, 924 (1955a).
Sabin, A.: Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. Ann. N. Y. Acad. Sci. 61, 1050 (1955b).
Sabin, A.: Present status of attenuated live-virus poliomyelitis vaccine. J. Amer. med. Ass. 162, 1589 (1956).
Sabin, A.: Present position of immunization against poliomyelitis with live virus vaccine. Brit. med. J. 1959, 5123.
Sabin, A.: Live, orally given poliovirus vaccine effects of rapid mass immunization on population under conditions of massive enteric infektion with other viruses. J. Amer. med. Ass. 173, 1521 (1960).
Sabin, A.: Eradication of poliomyelitis. Ann. intern. Med. 55, 353 (1961).
Sabin, A., and Olitzky 1936: Zit. n. Holt and McIntosh Pediatrics, 12th Edition, S. 1257 New York 1953.
Sabin, A., and Olitzky, M. Ramos Alvarez, J. Alvarez Amezquita, W. Pelon, R. Michaelis, S. Spigland, M. Koch, J. Barnes and J. Rhim: Effects of rapid mass immunization of a population with live oral poliovirus vaccine under conditions of massive enteric infection with other viruses. Second internat. conference on live poliovirus vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 377. Washington D. C., 1960.
Sabin, A., and Olitzky, M. Ramos Alvarez, J. Alvarez Amezquita, W. Pelon, R. Michaelis, S. Spigland, M. Koch, J. Barnes and J. Rhim R. Michaels, J. Spigland, W. Pelon, S. Rhim and R. Wehr: Community-wide use of oral poliovirus vaccine. Amer. J. Dis. Child. 101, 546 (1961).
Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger: Studies in human subjects on active immunization against poliomyelitis. J. Amer. med. Ass. 151, 1081 (19
Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner: Studies in Human Subjects on Active Immunization against Poliomyelitis. Am. J. publ. Hlth 44, 994 (1954).
Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner: A concept of the mechanism of immunity for preventing paralysis in poliomyelitis. Ann. N. Y. Acad. Sci. 61, 1023, (1955).
Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner: Poliomyelitis vaccine in fall of 1955. Am. J. publ. Hlth 46, 1 (1956).
Salk, J. E. Persistence of immunity after administration of formalin-treated poliovirus vaccine. Lancet 1960 II, 175.
Schär, M.: Stand der Schutzimpfungen mit Lebendvakzinen gegen die Poliomyelitis in der Schweiz. Bundesgesundheitsblatt 4, 220 (1960).
Schär, M.: Über die Erfahrungen mit der Schluckimpfung gegen die Poliomyelitis in der Schweiz. Bayer. Ärztebl. 17, 14 (1962).
Schaltenbrandt, G., H. Spuler u. H. C. Hopf: Neurologische Komplikationen nach Schutzimpfungen mit lebendem Poliomyelitisvirus nach Sabin. Münch. med. Wschr. 104, 1917 (1962).
Scheele-Bericht: 21. S. Deptm. of Health, Educ. and Welfare. Publ. Health Service, Washington D. C., 10. 6. 1955.
Seiffert, G.: Ergebnisse der oralen Impfung gegen Poliomyelitis in der DDR 1960 und Schlußfolgerungen daraus. Münch. med. Wschr. 103, 1268 (1961).
Siegel, M., and M. Greenberg: Poliomyelitis in pregnancy: Effect on fetus and newborn infant. J. Pediat. 49, 280 (1956).
Siegert, R., u. G. Enders-Ruckle: Zur Beurteilung zentralnervöser Impfschäden nach Poliomyelitis-Schutzimpfung mit inaktivierter Vakzine (Salk). Dtsch. med. Wschr. 86, 193 (1961).
Skovránek, K., and V. Záček: Oral poliovirus vaccine (Sabin) in Czeckoslovakia. J. Amer. med. Ass. 176, 524 (1961).
Smorodintsev, A., E. F. Davidenkova, A. J. Drobyshevskaya, T. E. Klyuchareva, V. J. Ilyenko, O. M. Chalkina, K. G. Vasiliev, E. V. Glyn-Skaya, V. J. Votiakov and E. V. Feldman: Material for the Study of the Harmless ness of the Live Poliomyelitis Vaccine prepared from Sabin Strains. First Internat. Conference on Live Poliomyelitis Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 44, 324. Washington D. C., 1959.
Smorodintsev, A. A.: Second internat. conference on live poliovirus vaccines. Discussion. Second internat. conference on live poliovirus vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 49. Washington D. C., 1960.
Smorodintsev, A. A.: Summary Report of the National Advisory Commitee für evaluation of Gammaglobulin. J. Amer. med. Ass. 154, 1086 (1954).
Truckenbrodt, H.: Über Gesundheitsstörungen nach Poliomyelitisschutzimpfung. Z. Kinderheilk. 86. 619 (1962).
Uehlinger, E.: Landrysche Paralyse nach Poliomyelitis-Schutzimpfung. Schweiz. med. Wschr. 87, 813 (1957).
Vivell, O.: Die Poliomyelitisschutzimpfung. Schutzimpfungen. Herausgeg. von H. Spiess. Stuttgart: G. Thieme 1958.
Vogt, M., R. Dulbecco and H. A. Wenner: Mutants of poliomyelitis viruses with reduced officiency of plating in grid medium and reduced neuropathogenicity. Virology 4, 141 (1957).
Vogt, D., u. E. Schaudig: Erfahrungen mit einem Kombinationsimpfstoff gegen Poliomyelitis, Diphtherie und Tetanus. Münch. med. Wschr. 102, 1084 (1960).
Wecker, E.: A simple test for serodifferentiation of poliovirus strains within the same type. Virology 10, 376 (1960).
Weihl, C., D. Cornfeld, H. D. Riley, N. Huang and H. Cramblett: Purified Poliomyelitis Vaccine-Clinical Appraisal. J. Amer. med. Ass. 176. 409 (1961).
Weissfeiler, J.: The control of poliomyelitis by live poliovirus vaccine. Akademiai Kiadó, Budapest 1961.
Wiesmann, E., u. T. Wegmann: Komplikationen nach peroraler Poliomyelitisschutzimpfung. Schweiz. med. Wschr. 92, 367 (1962).
Wilson, G. S., et al.: Poliomyelitis and tonsillectomie. Lancet 1955 II, 5.
Wilson, G. S., et al.: Poliomyelitis and prophylactic inoculation against Diphtherie, Whooping-Cough, and Smallipox Report of the Medical Research Council Committee on inoculation procedures and neurological lesions. Lancet.1956 II, 1223.
Windorfer, A.: Zur Frage der Poliomyelitis-Schutzimpfung während der Sommer-Herbst-Monate und während Epidemien. Dtsch. med. Wschr, 85. 1196 (1960).
Zimmerman, M. C.: Penicillinase — proved allergy to penicillin in poliomyelitis vaccine. J. Amer. med. Ass. 167, 1807 (1958).
Zischinsky, H., O. Pendl, Ch. Kunz u. K. Jellinger: Tödliche Encephalitis nach Poliomyelitis-Schutzimpfung. Klin. Wschr. 39, 638 (1961).
Editor information
Rights and permissions
Copyright information
© 1965 Springer-Verlag, Berlin/Heidelberg
About this chapter
Cite this chapter
Weber, G. (1965). Die Poliomyelitisschutzimpfung. In: Herrlich, A. (eds) Handbuch der Schutzimpfungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-92897-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-92897-0_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-92898-7
Online ISBN: 978-3-642-92897-0
eBook Packages: Springer Book Archive